Donepezil
RxNorm 135447
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 135447 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: donepezil.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Donepezil
(Atom ID: 930125)
PTPrescribable
Designated preferred name (PT):
Donepezil
(Atom ID: 930132)
FNPrescribable
Full form of descriptor (FN):
Donepezil (substance)
(Atom ID: 930134)
PTPrescribable
Designated preferred name (PT):
Donepezil-containing product
(Atom ID: 10801710)
FNPrescribable
Full form of descriptor (FN):
Product containing donepezil (medicinal product)
(Atom ID: 9256400)
Patient Education
Donepezil
Donepezil is used to treat dementia (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and may cause changes in mood and personality) in people who have Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Donepezil is in a class of medications called cholinesterase inhibitors. It improves mental function (such as memory, attention, the ability to interact with others, speak, think clearly, and perform regular daily activities) by increasing the amount of a certain naturally occurring substance in the brain. Donepezil may improve the ability to think and remember or slow the loss of these abilities in people who have AD. However, donepezil will not cure AD or prevent the loss of mental abilities at some time in the future.
[Learn More]
* Please review the disclaimer below.